Bank of Montreal’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $651K | Buy |
|
|||||
|
2025
Q1 | $587K | Buy |
|
|||||
|
2024
Q4 | $493K | Buy |
|
|||||
|
2024
Q3 | $426K | Buy |
|
|||||
|
2024
Q2 | $356K | Buy |
|
|||||
|
2024
Q1 | $303K | Buy |
|
|||||
|
2023
Q4 | $290K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $540K | Sell |
|
|||||
|
2021
Q4 | $741K | Sell |
|
|||||
|
2021
Q3 | $821K | Buy |
|
|||||
|
2021
Q2 | $190K | Sell |
|
|||||
|
2021
Q1 | $221K | Sell |
|
|||||
|
2020
Q4 | $346K | Buy |
|
|||||
|
2020
Q3 | $177K | Sell |
|
|||||
|
2020
Q2 | $247K | Buy |
|
|||||
|
2020
Q1 | $28K | Sell |
|
|||||
|
2019
Q4 | $444K | Buy |
|
|||||
|
2019
Q3 | $221K | Sell |
|
|||||
|
2019
Q2 | $274K | Buy |
|
|||||
|
2019
Q1 | $127K | Sell |
|
|||||
|
2018
Q4 | $1.36M | Buy |
|
|||||
|
2018
Q3 | $2.65M | Buy |
|
|||||
|
2018
Q2 | $1.94M | Sell |
|
|||||
|
2018
Q1 | $1.61M | Sell |
|
|||||
|
2017
Q4 | $1.36M | Buy |
|
|||||
|
2017
Q3 | $103K | Sell |
|
|||||
|
2017
Q2 | $700K | Sell |
|
|||||
|
2017
Q1 | $4.62M | Buy |
|
|||||
|
2016
Q4 | $2.34M | Sell |
|
|||||
|
2016
Q3 | $10.2M | Buy |
|
|||||
|
2016
Q2 | $301K | Sell |
|
|||||
|
2016
Q1 | $707K | Buy |
|
|||||
|
2015
Q4 | $692K | Buy |
|
|||||
|
2015
Q3 | $525K | Sell |
|
|||||
|
2015
Q2 | $668K | Buy |
|
|||||
|
2015
Q1 | $336K | Sell |
|
|||||
|
2014
Q4 | $247K | Sell |
|
|||||
|
2014
Q3 | $246K | Buy |
|
|||||
|
2014
Q2 | $90K | Buy |
|
|||||
|
2014
Q1 | $67K | Buy |
|
|||||
|
2013
Q4 | $15K | Sell |
|
|||||
|
2013
Q3 | $60K | Hold |
|
|||||
|
2013
Q2 | $52K | Buy |
|